Artigo de periodico

EGF (epidermal growth factor) receptor expression in blood: Prognostic biomarker in overall survival (OS) of patients with non-metastatic triple negative (TN) breast carcinoma. (2019)

• Authors:
  • ARAUJO, ROGERIO AGENOR DE
  • ARAÚJO, BRENO JEHA
  • Silva, Marcelo José Barbosa
  • Bernardino Neto, Morun
  • LUZ, FELIPE ANDRÉS CORDERO
  • DO AMARAL, PEDRO AUGUSTO
  • MARINHO, EDUARDA DA COSTA
  • NASCIMENTO, CAMILA PIQUI
  • MOSCA, ETELVINA ROCHA
  • DELFINO, PATRICIA FERREIRA RIBEIRO
  • ANTONIOLI, RAFAEL MATHIAS
  • MENDES, THAIS REZENDE
• Autor USP: BERNARDINO NETO, MORUN - EEL
• Unidade: EEL
• DOI: 10.1200/jco.2019.37.15_suppl.e14518
• Subjects: NEOPLASIAS; TUMOR CARCINOIDE
• Language: Inglês
• Abstract: EGF acts on tumor progression and its receptor can be measured by immunohistochemistry, or in the blood by immunoenzymatic method. This study quantified the expression of blood EGF receptors (bEGFR) in the molecular subtypes of breast carcinoma and their impact on OS.
• Imprenta:
  • Publisher place: Alexandria-VA
  • Date published: 2019
• Source:
  • Título: Journal of Clinical Oncology
  • ISSN: 15277755
  • Volume/Número/Paginação/Ano: v.37, n.15, p.e14518-e14518, 2019

Informações sobre o DOI: 10.1200/jco.2019.37.15_suppl.e14518 (Fonte: oaDOI API)
• Este periódico é de assinatura
• Este artigo NÃO é de acesso aberto
  
• Cor do Acesso Aberto: closed

---

How to cite

A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

• ABNT

  ARAUJO, ROGERIO AGENOR DE et al. EGF (epidermal growth factor) receptor expression in blood: Prognostic biomarker in overall survival (OS) of patients with non-metastatic triple negative (TN) breast carcinoma. Journal of Clinical Oncology, v. 37, n. 15, p. e14518-e14518, 2019Tradução . . Disponível em: https://doi.org/10.1200/jco.2019.37.15_suppl.e14518. Acesso em: 03 dez. 2025.

• APA

  ARAUJO, R. O. G. E. R. I. O. A. G. E. N. O. R. D. E., ARAÚJO, B. R. E. N. O. J. E. H. A., Silva, M. J. B., Bernardino Neto, M., LUZ, F. E. L. I. P. E. A. N. D. R. É. S. C. O. R. D. E. R. O., DO AMARAL, P. E. D. R. O. A. U. G. U. S. T. O., et al. (2019). EGF (epidermal growth factor) receptor expression in blood: Prognostic biomarker in overall survival (OS) of patients with non-metastatic triple negative (TN) breast carcinoma. Journal of Clinical Oncology, 37( 15), e14518-e14518. doi:10.1200/jco.2019.37.15_suppl.e14518

• NLM

  ARAUJO ROGERIOAGENORDE, ARAÚJO BRENOJEHA, Silva MJB, Bernardino Neto M, LUZ FELIPEANDRÉSCORDERO, DO AMARAL PEDROAUGUSTO, MARINHO EDUARDADACOSTA, NASCIMENTO CAMILAPIQUI, MOSCA ETELVINAROCHA, DELFINO PATRICIAFERREIRARIBEIRO, ANTONIOLI RAFAELMATHIAS, MENDES THAISREZENDE. EGF (epidermal growth factor) receptor expression in blood: Prognostic biomarker in overall survival (OS) of patients with non-metastatic triple negative (TN) breast carcinoma. [Internet]. Journal of Clinical Oncology. 2019 ;37( 15): e14518-e14518.[citado 2025 dez. 03 ] Available from: https://doi.org/10.1200/jco.2019.37.15_suppl.e14518

• Vancouver

  ARAUJO ROGERIOAGENORDE, ARAÚJO BRENOJEHA, Silva MJB, Bernardino Neto M, LUZ FELIPEANDRÉSCORDERO, DO AMARAL PEDROAUGUSTO, MARINHO EDUARDADACOSTA, NASCIMENTO CAMILAPIQUI, MOSCA ETELVINAROCHA, DELFINO PATRICIAFERREIRARIBEIRO, ANTONIOLI RAFAELMATHIAS, MENDES THAISREZENDE. EGF (epidermal growth factor) receptor expression in blood: Prognostic biomarker in overall survival (OS) of patients with non-metastatic triple negative (TN) breast carcinoma. [Internet]. Journal of Clinical Oncology. 2019 ;37( 15): e14518-e14518.[citado 2025 dez. 03 ] Available from: https://doi.org/10.1200/jco.2019.37.15_suppl.e14518

Últimas obras dos mesmos autores vinculados com a USP cadastradas na BDPI:

• Aging profile, adherence to the Elderly Health Handbook and health self-perception, Ituiutaba-MG (2015 and 2018)
• Expression of epidermal growth factor receptor (EGFR) in blood and tumor in patients with breast carcinoma: Prognostic analysis.
• Saúde Mental, Uso de Álcool e Qualidade do Sono em Estudantes de uma Universidade Pública
• Effects of acute and chronic exercise on the osmotic stability of erythrocyte membrane of competitive swimmers
• How effective is the use of glycemic variability in the follow-up of type 1 diabetes under intensive care?
• 227P The elusive luminal B breast tumor and the mysterious chemokines
• Swimming reduces fatty acids-associated hypothalamic damage in mice
• The elusive Luminal B breast cancer and the mysterious chemokines
• Correlations of the glycemic variability with oxidative stress and erythrocytes membrane stability in patients with type 1 diabetes under intensive treatment
• Influence of erythrocyte membrane stability in atherosclerosis